These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4812470)

  • 1. Editorial: The FDA and the supreme court.
    Dornette WH
    J Indiana State Med Assoc; 1974 Feb; 67(2):121-2. PubMed ID: 4812470
    [No Abstract]   [Full Text] [Related]  

  • 2. A strike against preemption.
    Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the Lannett and Pharmadyne decisions.
    Vetrano AJ
    Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dirty dancing--the FDA stumbles with the Chevron two-step: a response to professor Noah.
    Lawson G
    Cornell Law Rev; 2008 Jul; 93(5):927-38. PubMed ID: 18618964
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Some caveats for the FDA.
    Calif Med; 1973 Oct; 119(4):64-5. PubMed ID: 4749314
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Is the FDA too fearsome?
    Berry FB
    Med Times; 1973 Oct; 101(10):15 passim. PubMed ID: 4755498
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: FDA--approved?
    Collins CM
    J Fla Med Assoc; 1974 Jun; 61(6):458-9. PubMed ID: 4831239
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: The FDA reversed.
    Davis CE
    Va Med Mon (1918); 1974 Jan; 101(1):15-6. PubMed ID: 4809396
    [No Abstract]   [Full Text] [Related]  

  • 9. Court files order in pharmacies' case against FDA.
    J Am Vet Med Assoc; 2006 Oct; 229(8):1228. PubMed ID: 17066572
    [No Abstract]   [Full Text] [Related]  

  • 10. Has the Food and Drug Administration abused its authority in attempting to regulate veterinary compounding?
    Siegner AW
    J Am Vet Med Assoc; 1994 Jul; 205(2):243-7. PubMed ID: 7928589
    [No Abstract]   [Full Text] [Related]  

  • 11. Wyeth preemption case ruling sparks labeling confusion.
    Allison M
    Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
    [No Abstract]   [Full Text] [Related]  

  • 12. Compliance policy guideline enforcement issues.
    Mitchell B
    J Am Vet Med Assoc; 1994 Jul; 205(2):201-2. PubMed ID: 7928574
    [No Abstract]   [Full Text] [Related]  

  • 13. Legal restrictions on compounding.
    Geyer RE
    J Am Vet Med Assoc; 1994 Jul; 205(2):241-2. PubMed ID: 7928588
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 15. Personal responsibility and the Food and Drug Law.
    Janssen WF
    FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
    [No Abstract]   [Full Text] [Related]  

  • 16. Supreme Court opens door to personal injury suits against FDA.
    Smith GR
    Healthspan; 1988; 5(7):12-4. PubMed ID: 10288659
    [No Abstract]   [Full Text] [Related]  

  • 17. Supreme Court rules that FDA cannot regulate tobacco industry.
    Gottleib S
    BMJ; 2000 Apr; 320(7239):894. PubMed ID: 10787253
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pivotal medical-device case.
    Greenspan H
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514
    [No Abstract]   [Full Text] [Related]  

  • 20. A visit from the FDA.
    Brett J
    J Am Vet Med Assoc; 1994 May; 204(9):1319-20. PubMed ID: 8050959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.